Can Gubra drive value creating partner programs?
Gubra Partner Programs
Having engaged in a number of large partner programs, we have profound scientific capabilities and experience leading both target and drug discovery programs within Diabetes, Obesity, NASH and Gastrointestinal diseases.
Besides offering all necessary disciplines in-house (from molecular and in vivo pharmacology to peptide chemistry), we have professional project managers leading our partner programs. Projects are managed to meet deadlines and stay within budget while never compromising our high-quality outputs.
“When it comes to working with Gubra, I highly appreciate the strong scientific involvement and curiosity that permeates our collaborations. I cannot ask for a stronger partner in our human physiology and clinical research projects.”
MD, PhD, Director of Center for Diabetes Research | Gentofte Hospital, University of Copenhagen
Benefit from our extensive NASH know-how and test your compound in our validated DIO mouse model of NASH.
Qualify and advance your assessment of novel compounds to treat type 2 diabetes and diabetic complications.
Tap into our vast scientific experience with diet-induced obesity (DIO) models and other commercially available models.
Leverage our rodent models and stereological expertise to evaluate disease stages for example in inflammatory bowel disease.